← Every applicant

Davol, Inc., A Subsidiary of C.R. Bard, Inc. FDA Approvals

0 new drug approvals and 2 device clearances on file. This applicant is not matched to a listed company.

Newest first

A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.

Product
Phasix ST Parastomal Hernia Mesh510(k)Sep 28, 2026General, Plastic Surgery
Phasix ST Umbilical Hernia Patch510(k)Feb 19, 2025General, Plastic Surgery

Related datasets